No Detail Found!

Clinicopathological characteristics of carcinoma breast patients presenting to the surgical unit of a Tertiary Care Centre in Peshawar

Author(s)
Sana Sahar Department of Surgical Unit, Khyber Teaching Hospital,Peshawar -,Pakistan
Irum Sabir Ali Department of Surgical Unit, Khyber Teaching Hospital,Peshawar -,Pakistan
Anum Wahid Department of Surgical Unit, Khyber Teaching Hospital,Peshawar -,Pakistan
Mah Muneer Khan Department of Surgical Unit, Khyber Teaching Hospital,Peshawar -,Pakistan
Abstract
Objective: To determine the clinical and pathological features of patients with breast cancer presenting to the surgical unit of a tertiary care center in Peshawar. Materials and Methods: This cross-sectional descriptive study was conducted in Khyber Teaching Hospital, Peshawar from 1st January 2022 to 31st December 2022. Cases referred to the surgical unit for workup of breast cancer were recruited into the study by non-probability purposive sampling. After taking a detailed history and physical examination, a true cut biopsy of the breast lump was taken and sent for histopathology, receptor studies, and Ki67 scoring. Cases that were diagnosed previously in other hospitals were excluded. Data regarding age, menopausal status, histopathological diagnoses, receptor status, and stage of cancer were recorded and analyzed using SPSS version 26. Mean and standard deviation were used for quantitative variables while frequency and percentages were used for qualitative variables. Results: 230 patients with breast cancer were included in the study. The mean age of the study sample was 43±12.94 (range:17-85) years. 123 (53.5%) cases were premenopausal. Invasive ductal carcinoma was the most common diagnosis which was seen in 175 (76.1%) cases. Receptor status for estrogen and progesterone was positive in 135 (59.4%) and 107 (47.3.5%) cases respectively. 123 (53.3%) cases presented in the early stage of the disease while 34 (14.8%) cases were in the metastatic phase. Conclusion: Breast cancer presents at an early age in our population. Half of the affected population is premenopausal. Receptor status for estrogen and progesterone was positive in almost half of the population. Invasive ductal carcinoma breast is the most common diagnosis in our setup. Almost half of the population presents with the early stage of the disease.
Publication Details
Page(s) 121-125
Published Journal: Journal of Medical Science, Volume: 32, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Ki-67, Estrogen receptors, Invasive ductal carcinoma breast, Progesterone receptors
References
Mubarik S,Wang F,Luo L,Hezam K,Yu C .2023 .Evaluation of Lee-Carter model to breast cancer mortality prediction in China and Pakistan. , 13 : 1101249.
Lukasiewicz S,Czeczelewski M,Forma A,Baj J,Sitarz R,Stanisławek A .2021 .Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers, 13(17) : 4287.
Sohail SK,Sarfraz R,Imran M,Kamran M,Qamar S. Estrogen .2020 .and progesterone receptor expression in breast carcinoma and its association with clinicopathological variables among the pakistani population. Cureus, 12(8) : .
Khan R,Hashmi F,Bhatti AM,Memon AI .2023 .Locally Advanced Breast Cancer in Pakistani Women: Clinical Features and Prognostic Factors: Breast Cancer Prognostic Features. Pak J Health Sci, : 31-4.
Munawwar A,Sajjad A,Faisal S,Rasul A,Zarbab A,Bibi A,Study. Iran J Pub Health A Retrospective .2023 .Basic Findings of Incidence of Breast Cancer in Allied Hospital Faisalabad. , 52(6) : 1199.
Tufail M,Wu C .2023 .Exploring the Burden of Cancer in Pakistan: An Analysis of 2019 Data. J Epidemiol Global Health, : 1-11.
Zeeshan S,Ali B,Ahmad K,Chagpar AB,Sattar AK .2019 .Clinicopathological features of young versus older patients with breast cancer at a single Pakistani institution and a comparison with a national US database. J Global oncol, 5 : 1-6.
McGuire A,Brown JA,Malone C,McLaughlin R,Kerin MJ R .2015 .Effects of age on the detection and management of breast cancer. Cancers, 7(2) : 908-29.
Fatehi P,Mahboubi-Fooladi Z,Dastmardi M,Esfehani RJ,Bagheri AK .2023 .The correlation between imaging findings and breast cancer cell receptors status. J Med Imaging and Rad Sci, : .
Nasrazadani A,Thomas RA,Oesterreich S,Lee AV .2018 .Precision medicine in hormone receptor-positive breast cancer. Frontiers oncol, 8 : 144.
Wu J-R,Zhao Y,Zhou X-P,Qin X .2020 .Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis. Biomed & Pharmacotherapy, 121 : 109647.
Albert JM,Gonzalez-Angulo AM,Guray M,Sahin A,Strom EA,Tereffe W .2010 .Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer. International Journal of Radiation Oncology* Biology* Physics, 77(5) : 1296-302.
Furrer D,Paquet C,Jacob S,Diorio C. .2018 .The human epidermal growth factor receptor 2 (HER2) as a prognostic and predictive biomarker: Molecular insights into HER2 activation and diagnostic implications. Cancer prog, 5 : 11-21.
Motta JM,Hassan H,Ibrahim SA .2023 .Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma. Cancers, 15(6) : 1794.
Hu X,Chen W,Li F,Ren P,Wu H,Zhang C .2023 .Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance. Frontiers Oncol, 13 : 1053125.
Inwald E,Klinkhammer-Schalke M,Hofstädter F,Zeman F,Koller M,Gerstenhauer M .2013 .-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast can res treat, 139 : 539-52.
Badar F,Mahmood S,Faraz R,Yousaf A,Quader AU,Asif H .2015 .Epidemiology of breast cancer at the Shaukat Khanum memorial cancer hospital and research center, Lahore, Pakistan. J Coll Physicians Surg Pak, 25(10) : 738-42.
Lateef F,Jamal S,Nasir S .2017 .Invasive ductal carcinoma: correlation of immunophenotypic features with age. J Coll Physicians Surg Pak, 27(1) : 18-22.
Kang SY,Kim YS,Kim Z,Kim H-Y,Lee SK,Jung K-W .2018 .Basic findings regarding breast cancer in Korea in 2015: data from a breast cancer registry. J of breast can, 21(1) : 1-10.
Zeng H,Zheng R,Zhang S,Zou X,Chen W. .2014 .Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. J thorac dis, 6(5) : 466.
Benz CC .2008 .Impact of aging on the biology of breast cancer. Critical reviews in oncol/hematol, 66(1) : 65-74.
Siegel R,Ma J,Zou Z,Jemal A .2014 .a cancer journal for clinicians. , 64(1) : 9-29.
Kumar K,Akhtar M,Rangwala M. .2019 .Breast cancer: correlation of receptor status with clinical presentation, stage of disease, histopathological grade and short term outcome. Int Surg J, 6(4) : 1323-6.
Singh R,Gupta S,Pawar SB,Pawar RS,Gandham S,Prabhudesai S .2014 .Evaluation of ER, PR and HER-2 receptor expression in breast cancer patients presenting to a semi urban cancer centre in Western India. J can research and therapeutics., 10(1) : 26-8.
Hashmi AA,Aijaz S,Khan SM,Mahboob R,Irfan M,Zafar NI .2018 .Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients. World j surg oncol, 16 : 1-6.
Yang M,Sun J,Liu L,Kong X,Lin D,Zhou H .2023 .Clinicopathological characteristics of HER2-low breast cancer: a retrospective study. Scientific Reports, 13(1) : 12382.
0

Citations

0

Downloads

49

Views